evrysdi
roche registration gmbh - risdiplam - mišična atrofija, hrbtenica - druga zdravila za motnje mišično-skeletnega sistema - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.
clavaseptin 50, 250, 500 mg palatable tablets
vetoquinol magny -
clavaseptin 62,5 mg tablete
vetoquinol magny -
cephalexin
genera si -
cladaxxa
krka -
percarnil combo 4 mg/1,25 mg tablete
actavis group ptc ehf. - indapamid; perindopril - tableta - indapamid 1,25 mg / 1 tableta perindopril3,34 mg / 1 tableta; perindopril 3,34 mg / 1 tableta - perindopril in diuretiki
percarnil combo 2 mg/0,625 mg tablete
actavis group ptc ehf. - indapamid, perindopril - tableta - indapamid 0,625 mg / 1 tableta; perindopril 1,67 mg / 1 tableta - perindopril in diuretiki